Cargando…

ADAR1 regulates vascular remodeling in hypoxic pulmonary hypertension through N1-methyladenosine modification of circCDK17

Pulmonary hypertension (PH) is an extremely malignant pulmonary vascular disease of unknown etiology. ADAR1 is an RNA editing enzyme that converts adenosine in RNA to inosine, thereby affecting RNA expression. However, the role of ADAR1 in PH development remains unclear. In the present study, we inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Junting, Li, Yiying, Zhang, Jianchao, Liu, Lu, Chen, Yuan, Yang, Xusheng, Liao, Xueyi, He, Muhua, Jia, Zihui, Fan, Jun, Bian, Jin-Song, Nie, Xiaowei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692360/ https://www.ncbi.nlm.nih.gov/pubmed/38045055 http://dx.doi.org/10.1016/j.apsb.2023.07.006

Ejemplares similares

CircCDK14 Promotes Tumor Progression and Resists Ferroptosis in Glioma by Regulating PDGFRA
por: Chen, Simin, et al.
Publicado: (2022)

CircCDK14 protects against Osteoarthritis by sponging miR-125a-5p and promoting the expression of Smad2
por: Shen, Panyang, et al.
Publicado: (2020)

CircCDK17 knockdown inhibits tumor progression and cell glycolysis by downregulaing YWHAZ expression through sponging miR-1294 in cervical cancer
por: Chen, Rui, et al.
Publicado: (2022)

CDK13 upregulation-induced formation of the positive feedback loop among circCDK13, miR-212-5p/miR-449a and E2F5 contributes to prostate carcinogenesis
por: Qi, Jin-Chun, et al.
Publicado: (2021)

The ADAR1 editome reveals drivers of editing-specificity for ADAR1-isoforms
por: Kleinova, Renata, et al.
Publicado: (2023)

Roles of miR-432 and circ_0000418 in mediating the anti-depressant action of ADAR1
por: Zhang, Xiaonan, et al.
Publicado: (2021)

An ADAR1-dependent RNA editing event in the cyclin-dependent kinase CDK13 promotes thyroid cancer hallmarks
por: Ramírez-Moya, Julia, et al.
Publicado: (2021)

N(6)-methyladenosine promotes induction of ADAR1-mediated A-to-I RNA editing to suppress aberrant antiviral innate immune responses
por: Terajima, Hideki, et al.
Publicado: (2021)

ADAR1 restricts LINE-1 retrotransposition
por: Orecchini, Elisa, et al.
Publicado: (2017)

circRNA N6-methyladenosine methylation in preeclampsia and the potential role of N6-methyladenosine-modified circPAPPA2 in trophoblast invasion
por: Zhang, Yonggang, et al.
Publicado: (2021)

RNA editing enzyme ADAR1 is required for early T cell development
por: Xufeng, Richard, et al.
Publicado: (2020)

N(6)-methyladenosine is required for the hypoxic stabilization of specific mRNAs
por: Fry, Nate J., et al.
Publicado: (2017)

Comprehensive of N1-Methyladenosine Modifications Patterns and Immunological Characteristics in Ovarian Cancer
por: Liu, Jinhui, et al.
Publicado: (2021)

ADAR1-mediated regulation of melanoma invasion
por: Nemlich, Yael, et al.
Publicado: (2018)

ADAR1 Editing and its Role in Cancer
por: Xu, Li-Di, et al.
Publicado: (2018)

Functional conservation in human and Drosophila of Metazoan ADAR2 involved in RNA editing: loss of ADAR1 in insects
por: Keegan, Liam P., et al.
Publicado: (2011)

Optimal guideRNAs for re-directing deaminase activity of hADAR1 and hADAR2 in trans
por: Schneider, Marius F., et al.
Publicado: (2014)

ADAR1 silencing-induced HUVEC apoptosis is mediated by FGFR2 under hypoxia stress
por: Jiang, Yun, et al.
Publicado: (2018)

The N6-methyladenosine demethylase ALKBH5 regulates the hypoxic HBV transcriptome.
por: Tsukuda, Senko, et al.
Publicado: (2023)

Identification and characterization of N6‐methyladenosine modification of circRNAs in glioblastoma
por: Zhang, Yuhao, et al.
Publicado: (2021)

RNA Editing, ADAR1, and the Innate Immune Response
por: Wang, Qingde, et al.
Publicado: (2017)

ADAR1: “Editor-in-Chief” of Cytoplasmic Innate Immunity
por: Lamers, Mart M., et al.
Publicado: (2019)

ADAR1: a mast regulator of aging and immunity
por: Zhang, Yigan, et al.
Publicado: (2023)

ADAR1 Alleviates Inflammation in a Murine Sepsis Model via the ADAR1-miR-30a-SOCS3 Axis
por: Shangxun, Zhou, et al.
Publicado: (2020)

Hepatocellular carcinoma progression mediated by hepatitis B virus-encoded circRNA HBV_circ_1 through interaction with CDK1
por: Zhu, Min, et al.
Publicado: (2021)

The ADAR protein family
por: Savva, Yiannis A, et al.
Publicado: (2012)

BCAT1 binds the RNA-binding protein ZNF423 to activate autophagy via the IRE1-XBP-1-RIDD axis in hypoxic PASMCs
por: Xin, Wei, et al.
Publicado: (2020)

ADAR1- and ADAR2-mediated regulation of maturation and targeting of miR-376b to modulate GABA neurotransmitter catabolism
por: Widmark, Albin, et al.
Publicado: (2022)

ZBP1 contributes to interferonopathies caused by impaired ADAR1 function
por: Fang, Xiuwu, et al.
Publicado: (2022)

Correction: BCAT1 binds the RNA-binding protein ZNF423 to activate autophagy via the IRE1-XBP-1-RIDD axis in hypoxic PASMCs
por: Xin, Wei, et al.
Publicado: (2021)

Loss of ADAR1 in macrophages in combination with interferon gamma suppresses tumor growth by remodeling the tumor microenvironment
por: Lin, Weiwei, et al.
Publicado: (2023)

Modulation of ADAR1 editing activity by Z-RNA in vitro
por: Koeris, Michael, et al.
Publicado: (2005)

ADAR1 is essential for maintenance of hematopoiesis and suppression of interferon signaling
por: Hartner, Jochen C., et al.
Publicado: (2008)

ADAR1 is essential for intestinal homeostasis and stem cell maintenance
por: Qiu, W, et al.
Publicado: (2013)

ADAR1 overexpression is associated with cervical cancer progression and angiogenesis
por: Chen, Ying, et al.
Publicado: (2017)

ADAR1 and MicroRNA; A Hidden Crosstalk in Cancer
por: Cho, Charles J., et al.
Publicado: (2017)

Deciphering the Biological Significance of ADAR1–Z-RNA Interactions
por: Nakahama, Taisuke, et al.
Publicado: (2021)

ADAR1-Mediated RNA Editing and Its Role in Cancer
por: Liu, Jizhe, et al.
Publicado: (2022)

Targeting the androgen receptor to enhance NK cell killing efficacy in bladder cancer by modulating ADAR2/circ_0001005/PD-L1 signaling
por: Liu, Qing, et al.
Publicado: (2022)

N6-methyladenosine modification of circCUX1 confers radioresistance of hypopharyngeal squamous cell carcinoma through caspase1 pathway
por: Wu, Ping, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rtpf34gd27inbqndgdt9a8tm47